25 Aug 2023 1H23 revenue down by 28% YoY
CROSBY Research – Canvest (1381 HK/BUY): Higher revenue contribution from operation segment
CROSBY Research – Xtep (1368 HK/BUY): Solid 1H23 revenue growth, full year sales growth target 15-20% YoY
24 Aug 2023 Xtep’s 1H23 revenue was up b
CROSBY Research – Vincent Medical (1612 HK/BUY): Staging a turnaround in 1H23
24 Aug 2023 In 1H23, Vincent Medical’s (
CROSBY Research – Pagoda (2411 HK): Widening NPM on operational efficiency and cost savings
22 Aug 2023 The company reported a 6.4%
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 41)
21 Aug 2023 Hong Kong’s population
CROSBY Research – China Lilang (1234 HK): Single digit growth in 1H23
18 Aug 2023 The company reported a 6.7%
CROSBY Research – 361 Degrees (1361 HK/BUY): Promising outlook
17 Aug 2023 1H23 revenue increased by 18
CROSBY Research – Pentamaster (1665 HK/BUY): Steady 2Q23 revenue growth, medical devices will drive 2H23 momentum
16 Aug 2023 Pentamaster’s 2Q23 revenue i
CROSBY Research – Greentech(1257 HK/BUY): Increasing EBITDA for its biomass segment
15 Aug 2023 CEG’s 1H23 revenue was down
CROSBY Research – SIIC (807 HK): Growth driven by the new Baoshan project
14 Aug 2023 SIIC’s 1H23 revenue increase